| 5822- | capec, | Capecitabine as Adjuvant Treatment for Stage III Colon Cancer |
| - | Trial, | Colon, | NA |
| 5821- | capec, | docx, | Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results |
| - | Trial, | BC, | NA |
| 5883- | CAR, | Safety and tolerability of carvacrol in healthy subjects: a phase I clinical study |
| - | Trial, | Nor, | NA |
| 5889- | CAR, | Effect of carvacrol on pulmonary function tests, and total and differential white blood cell counts in healthy volunteers: A randomized clinical trial |
| - | Trial, | Nor, | NA |
| 3880- | Carno, | EFFECT OF ANSERINE/CARNOSINE SUPPLEMENTATION ON THE PREVENTION OF ALZHEIMER'S DISEASE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT |
| - | Trial, | AD, | NA |
| 5929- | Catechins, | Phase I trial of oral green tea extract in adult patients with solid tumors |
| - | Trial, | Var, | NA |
| 5930- | Catechins, | Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention |
| - | Trial, | Pca, | NA |
| 5916- | Cats, | Chemo, | Uncaria tomentosa—Adjuvant Treatment for Breast Cancer: Clinical Trial |
| - | Trial, | BC, | NA |
| 5917- | Cats, | Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial |
| - | Trial, | CRC, | NA |
| 5918- | Cats, | Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors |
| - | Trial, | Var, | NA |
| 5812- | CBD, | Cannabidiol oil or placebo in advanced cancer-disease progression and survival: a secondary analysis |
| - | Trial, | Var, | NA |
| 5966- | CEL, | Determine whether administering celecoxib during radiotherapy can reduce the risk of recurrence of triple-negative breast cancer. Pilot study |
| - | Trial, | BC, | NA |
| 5960- | CEL, | Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers |
| - | Trial, | Pca, | NA |
| 6635- | Cen, | Pharmacokinetics and metabolomics investigation of an orally modified formula of standardized Centella asiatica extract in healthy volunteers |
| - | Trial, | Nor, | NA |
| 6636- | Cen, | Pharmacokinetics and Pharmacodynamics of Key Components of a Standardized Centella asiatica Product in Cognitively Impaired Older Adults: A Phase 1, Double-Blind, Randomized Clinical Trial |
| - | Trial, | AD, | NA |
| 6659- | Cen, | Effect of Centella asiatica on mild cognitive impairment (MCI) and other common age-related clinical problems |
| - | Trial, | AD, | NA |
| 6657- | Cen, | Safety and Target Engagement of Centella Asiatica in Cognitive Impairment |
| - | Trial, | AD, | NA |
| 6646- | Cen, | Effectiveness of Gotu Kola Extract 750 mg and 1000 mg Compared with Folic Acid 3 mg in Improving Vascular Cognitive Impairment after Stroke |
| - | Trial, | Stroke, | NA |
| 5972- | CET, | Rad, | Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer |
| - | Trial, | HNSCC, | NA |
| 6024- | CGA, | Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up |
| - | Trial, | GBM, | NA |
| 6041- | CGA, | Effect of Chlorogenic Acid Intake on Cognitive Function in the Elderly: A Pilot Study |
| - | Trial, | AD, | NA |
| 6036- | CGA, | Effect of Chlorogenic Acids on Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Trial, | Nor, | NA |
| 6035- | CGA, | Effect of Chlorogenic Acids on Cognitive Function in Mild Cognitive Impairment: A Randomized Controlled Crossover Trial |
| - | Trial, | Nor, | NA |
| 6029- | CGA, | Pharmacokinetics of chlorogenic acids absorbed in human plasma and their metabolites following oral ingestion of coffee drink |
| - | Trial, | Nor, | NA |
| 6028- | CGA, | Chlorogenic acids from green coffee extract are highly bioavailable in humans |
| - | Trial, | Nor, | NA |
| 5998- | Chit, | Trial: Chitosan can help reduce AGE levels in patients with prostate cancer. |
| - | Trial, | Pca, | NA |
| 4476- | Chit, | Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial |
| - | Trial, | NA, | NA |
| 6071- | CHL, | First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent |
| - | Trial, | Nor, | NA |
| 6087- | CHOC, | Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial |
| - | Trial, | Nor, | NA |
| 6088- | CHOC, | Effect of chocolate on older patients with cancer in palliative care: a randomised controlled study |
| - | Trial, | Var, | NA |
| - | Trial, | Nor, | NA |
| 6150- | Chol, | Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial |
| - | Trial, | AD, | NA |
| 6117- | Chol, | Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
| - | Trial, | AD, | NA |
| 6120- | Chol, | Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease |
| - | Trial, | AD, | NA |
| 6134- | CHr, | QC, | RT, | Comparative Pharmacokinetics and Safety of a Micellar Chrysin–Quercetin–Rutin Formulation: A Randomized Crossover Trial |
| - | Trial, | Nor, | NA |
| 7433- | Chy, | Evaluation of Cyavanaprāśa on Health and Immunity related Parameters in Healthy Children: A Two Arm, Randomized, Open Labeled, Prospective, Multicenter, Clinical Study |
| - | Trial, | Nor, | NA |
| 7432- | Chy, | A Cytogenetic Study on the Efficacy of Chyawanprash Awaleha as an Antioxidant in Oral Premalignant Cancer |
| - | Trial, | Oral, | NA |
| 6152- | CoQ10, | doxoR, | Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment |
| - | Trial, | BC, | NA |
| 4257- | CoQ10, | Dietary intake of coenzyme Q10 reduces oxidative stress in patients with acute ischemic stroke: a double-blind, randomized placebo-controlled study |
| - | Trial, | Stroke, | NA |
| 6368- | CPLE, | Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial |
| - | Trial, | Var, | NA |
| - | Trial, | Var, | NA |
| 3625- | Cro, | Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial |
| - | Trial, | AD, | NA |
| 3626- | Cro, | Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial |
| - | Trial, | AD, | NA |
| 3634- | Cro, | A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease |
| - | Trial, | AD, | NA |
| 7421- | CS, | Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial |
| - | Trial, | Nor, | NA |
| 7417- | CS, | CGA, | Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans |
| - | Trial, | Nor, | NA |
| 7419- | CS, | Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial |
| - | Trial, | Nor, | NA |
| - | Trial, | Obesity, | NA |
| 6226- | CUR, | Rad, | Analysis of Curcumin as a Radiosensitizer in Cancer Therapy with Serum Survivin Examination: Randomised Control Trial |
| - | Trial, | Cerv, | NA |
| 6208- | CUR, | Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial |
| - | Trial, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid